Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Accesswire January 25, 2023

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm's Attorneys, Securities Class Action Pending

Newsfile January 25, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST

Newsfile January 25, 2023

Twist Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2023 to Discuss Your Rights - TWST

Newsfile January 25, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)

PR Newswire January 25, 2023

Twist Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2023 to Discuss Your Rights - TWST

Newsfile January 24, 2023

TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders

PR Newswire January 24, 2023

TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Twist Bioscience Corporation (NASDAQ: TWST)

PR Newswire January 24, 2023

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TWST

PR Newswire January 23, 2023

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit

PR Newswire January 23, 2023

Twist Class Action: Levi & Korsinsky Reminds Twist Bioscience Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2023 - TWST

Newsfile January 23, 2023

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Twist Investors of a Lead Plaintiff Deadline of February 10, 2023

PR Newswire January 23, 2023

TWST Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 10, 2023 Deadline in Securities Fraud Class Action Lawsuit against Twist Bioscience Corporation

PR Newswire January 21, 2023

TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST

PR Newswire January 20, 2023

TWST NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST

Newsfile January 20, 2023

Kessler Topaz Meltzer & Check, LLP Announces it Has Filed a Securities Fraud Class Action Lawsuit against Twist Bioscience Corporation

Newsfile January 20, 2023

TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023

PR Newswire January 20, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST

PR Newswire January 20, 2023

HAGENS BERMAN Alerts Twist Bioscience (TWST) Investors to Approaching Deadline in Securities Fraud Class Action, Encourages Investors with Losses to Contact Firm's Attorneys

Newsfile January 19, 2023

Grabar Law Office Investigates Claims on Behalf of Shareholders of Twist Bioscience Corp. (TWST)

Newsfile January 19, 2023